Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and miceLin Wang, Spencer A. Freeman, Melania Capitani et al.|Nature Genetics|2021Cited by 106
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaireSarah C. Grünert, Hester C. Schuman, Terry G. J. Derks et al.|Genetics in Medicine|2022Cited by 64
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised PatientsEssack Mitha, Loreta Vareikiene, Gergely Kriván et al.|Infectious Diseases and Therapy|2019Cited by 26